tiprankstipranks
Trending News
More News >
Lotus Pharmaceuticals Inc (LTUS)
OTHER OTC:LTUS
US Market

Lotus Pharmaceuticals (LTUS) Income Statement

Compare
4 Followers

Lotus Pharmaceuticals Income Statement

Last quarter (Q2 2024), Lotus Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Lotus Pharmaceuticals's net income was $-2.50K. See Lotus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 18.81K$ 21.11K$ 30.41K$ 6.28K$ -21.83K
Depreciation and Amortization
$ 167.90K$ 228.49K$ 236.56K$ 206.30K$ 171.86K
EBITDA
$ -18.81K$ -21.11K$ -30.41K$ -6.28K$ -21.83K
Operating Income
$ -18.81K$ -21.11K$ -30.41K$ -6.28K$ -21.83K
Other Income/Expenses
$ 0.00$ 0.00$ -3.00$ -3.00$ 0.00
Pretax Income
$ -18.81K$ -21.11K$ -30.41K$ -6.28K$ 0.00
Net Income
$ -18.81K$ -21.11K$ -30.41K$ -6.28K$ -21.83K
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Diluted EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding
2.69B 2.69B 2.94B 2.94B 2.79B
Weighted Average Shares Outstanding (Diluted)
2.69B 2.69B 2.94B 2.94B 2.79B
Currency in USD

Lotus Pharmaceuticals Earnings and Revenue History